The estimated Net Worth of Samarth Kulkarni is at least $6,656,683.74. Samarth Kulkarni owns over 166,542 units of CRISPR Therapeutics AG stock worth over $6,656,683.74.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 1st March 2019 | CRSP - CRISPR Therapeutics AG | 748 | Payment by withholding | 166,542 | $39.97 | $29,897.56 | $6,656,683.74 |
| 29th April 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Open or private sale | 166,542 | $42.03 | $840,600.00 | $6,999,760.26 |
| 29th April 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 186,542 | $1.81 | $36,200.00 | $337,641.02 |
| 1st June 2019 | CRSP - CRISPR Therapeutics AG | 741 | Payment by withholding | 165,801 | $35.57 | $26,357.37 | $5,897,541.57 |
| 17th June 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Open or private sale | 165,801 | $46.00 | $920,000.00 | $7,626,846.00 |
| 17th June 2019 | CRSP - CRISPR Therapeutics AG | 20,000 | Exercise of derivative | 185,801 | $1.81 | $36,200.00 | $336,299.81 |
| 1st September 2019 | CRSP - CRISPR Therapeutics AG | 740 | Payment by withholding | 165,061 | $46.21 | $34,195.40 | $7,627,468.81 |
| 1st December 2019 | CRSP - CRISPR Therapeutics AG | 741 | Payment by withholding | 164,320 | $71.65 | $53,092.65 | $11,773,528.00 |
| 16th December 2019 | CRSP - CRISPR Therapeutics AG | 8,000 | Exercise of derivative | 172,320 | $1.81 | $14,480.00 | $311,899.20 |
| 2nd March 2020 | CRSP - CRISPR Therapeutics AG | 794 | Payment by withholding | 171,526 | $52.74 | $41,875.56 | $9,046,281.24 |
| 20th May 2020 | CRSP - CRISPR Therapeutics AG | 10,693 | Open or private sale | 171,526 | $65.28 | $698,039.04 | $11,197,217.28 |
| 20th May 2020 | CRSP - CRISPR Therapeutics AG | 10,693 | Exercise of derivative | 182,219 | $1.81 | $19,354.33 | $329,816.39 |
| 19th May 2020 | CRSP - CRISPR Therapeutics AG | 4,307 | Open or private sale | 171,526 | $65.16 | $280,644.12 | $11,176,634.16 |
| 19th May 2020 | CRSP - CRISPR Therapeutics AG | 4,307 | Exercise of derivative | 175,833 | $1.81 | $7,795.67 | $318,257.73 |
| 2nd June 2020 | CRSP - CRISPR Therapeutics AG | 779 | Payment by withholding | 170,747 | $66.26 | $51,616.54 | $11,313,696.22 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 5,575 | Open or private sale | 171,526 | $65.26 | $363,824.50 | $11,193,786.76 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 9,300 | Open or private sale | 177,101 | $64.61 | $600,873.00 | $11,442,495.61 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 2,400 | Open or private sale | 186,401 | $63.57 | $152,568.00 | $11,849,511.57 |
| 1st June 2020 | CRSP - CRISPR Therapeutics AG | 17,275 | Exercise of derivative | 188,801 | $1.81 | $31,267.75 | $341,729.81 |
| 2nd September 2020 | CRSP - CRISPR Therapeutics AG | 779 | Payment by withholding | 169,968 | $94.15 | $73,342.85 | $16,002,487.20 |